| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.029 | 0.6 |